Cargando…

Comment on: Impact of postoperative chemotherapy on survival for oesophagogastric adenocarcinoma after preoperative chemotherapy and surgery

Detalles Bibliográficos
Autores principales:	Liu, Kai, Zhang, Wei han, Hu, Jian kun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10364706/ https://www.ncbi.nlm.nih.gov/pubmed/35583148 http://dx.doi.org/10.1093/bjs/znac129

Ejemplares similares

Author response to: Impact of postoperative chemotherapy on survival for oesophagogastric adenocarcinoma after preoperative chemotherapy and surgery
por: Rahman, Saqib A, et al.
Publicado: (2022)

Impact of postoperative chemotherapy on survival for oesophagogastric adenocarcinoma after preoperative chemotherapy and surgery
por: Rahman, Saqib, et al.
Publicado: (2021)

Systemic chemotherapy for gastro-oesophagogastric junction adenocarcinoma and stomach adenocarcinoma in a metastatic setting
por: Sanjeevaiah, Aravind, et al.
Publicado: (2020)

Analysis of the Survival Impact of Postoperative Chemotherapy After Preoperative Chemotherapy and Resection for Gastric Cancer
por: Drake, Justin A., et al.
Publicado: (2020)

Comment on: Increasing frequency of gene copy number aberrations is associated with immunosuppression and predicts poor prognosis in gastric adenocarcinoma
por: Liu, Kai, et al.
Publicado: (2022)

Impact of the Siewert Classification on the Outcome of Patients Treated by Preoperative Chemoradiotherapy for a Nonmetastatic Adenocarcinoma of the Oesophagogastric Junction
por: Moureau-Zabotto, Laurence, et al.
Publicado: (2015)

Detecting and Tracking Circulating Tumour DNA Copy Number Profiles during First Line Chemotherapy in Oesophagogastric Adenocarcinoma
por: Davidson, Michael, et al.
Publicado: (2019)

Single-institute comparison of the efficacy of systemic chemotherapy for oesophagogastric junction adenocarcinoma and stomach adenocarscinoma in a metastatic setting
por: Nakayama, Izuma, et al.
Publicado: (2020)

Nomogram-based prediction of survival in patients with advanced oesophagogastric adenocarcinoma receiving first-line chemotherapy: a multicenter prospective study in the era of trastuzumab
por: Custodio, A, et al.
Publicado: (2017)

Impact of Postoperative Chemotherapy in Patients with Gastric/Gastroesophageal Adenocarcinoma Treated with Perioperative Chemotherapy
por: Ballhausen, Alexej, et al.
Publicado: (2022)

FLOT and CROSS chemotherapy regimens alter the frequency of CD27(+) and CD69(+) T cells in oesophagogastric adenocarcinomas: implications for combination with immunotherapy
por: Davern, Maria, et al.
Publicado: (2022)

Rechallenge pemetrexed-based chemotherapy provides an option for initially benefited patients with advanced lung adenocarcinoma
por: Wang, Jia-Ni, et al.
Publicado: (2021)

Recurrence after preoperative chemotherapy and surgery for gastric adenocarcinoma: a multicenter study
por: Mokadem, I., et al.
Publicado: (2019)

Perioperative Therapy of Oesophagogastric Adenocarcinoma: Mainstay and Future Directions
por: Bose, Katrin, et al.
Publicado: (2017)

Relevance of MTHFR polymorphisms with response to fluoropyrimidine-based chemotherapy in oesophagogastric cancer: a meta-analysis
por: Zhong, Lei, et al.
Publicado: (2018)

Comment on “Heterogeneity in PD-L1 expression in malignant peritoneal mesothelioma with systemic or intraperitoneal chemotherapy”
por: Yang, Haitang, et al.
Publicado: (2020)

Does the RAPIDO trial suggest a benefit of post-operative chemotherapy after preoperative chemoradiation in rectal cancer? No, it does not.
por: Socha, J., et al.
Publicado: (2023)

Response to Comment on “Heterogeneity in PD-L1 expression in malignant peritoneal mesothelioma with systemic or intraperitoneal chemotherapy”
por: White, Michael G., et al.
Publicado: (2020)

Esophagogastric junction adenocarcinoma: Preoperative chemoradiation or perioperative chemotherapy?
por: Laxague, Francisco, et al.
Publicado: (2021)

The impact of taxane-based preoperative chemotherapy in gastroesophageal signet ring cell adenocarcinomas
por: Kim, Stefano, et al.
Publicado: (2015)

Characterising timing and pattern of relapse following surgery for localised oesophagogastric adenocarcinoma: a retrospective study
por: Moorcraft, Sing Yu, et al.
Publicado: (2016)

S-1 and oxaliplatin combined with nanoparticle albumin-bound paclitaxel adjuvant chemotherapy for advanced gastric adenocarcinoma
por: Xia, Yu, et al.
Publicado: (2022)

Authors’ reply—Does the RAPIDO trial suggest a benefit of post-operative chemotherapy after preoperative chemoradiation in rectal cancer? No, it does not
por: Zwart, W.H., et al.
Publicado: (2023)

The impact of adjuvant chemotherapy on survival in mucinous and non-mucinous rectal adenocarcinoma patients after TME surgery
por: Vernmark, Karolina, et al.
Publicado: (2023)

A population-based observational study on the factors associated with the completion of palliative chemotherapy among patients with oesophagogastric cancer
por: Groene, Oliver, et al.
Publicado: (2015)

Adjuvant chemotherapy may be unnecessary for ypT0-2N0 gastric cancer patients after neoadjuvant chemotherapy and curative gastrectomy
por: Shao, Xinxin, et al.
Publicado: (2023)

Nomogram for predicting the survival of gastric adenocarcinoma patients who receive surgery and chemotherapy
por: Wang, Chao-Yang, et al.
Publicado: (2020)

Trimodality therapy versus perioperative chemotherapy in the management of locally advanced adenocarcinoma of the oesophagus and oesophagogastric junction (Neo-AEGIS): an open-label, randomised, phase 3 trial
por: Reynolds, John V, et al.
Publicado: (2023)

Chemotherapy in Bacillary Dysentery
por: Roy, S. C. Guha
Publicado: (1942)

Local Chemotherapy of Wounds
por: Biswas, J. C.
Publicado: (1942)

Prognostic value of histopathological regression in 850 neoadjuvantly treated oesophagogastric adenocarcinomas
por: Schmidt, T, et al.
Publicado: (2014)

Letter to the editor regarding ‘Preoperative data-based deep learning model for predicting postoperative survival in pancreatic cancer patients’
por: Zhao, Miaoying
Publicado: (2023)

Impact of neoadjuvant chemotherapy and postoperative adjuvant chemotherapy cycles on survival of patients with advanced-stage ovarian cancer
por: Chung, Young Shin, et al.
Publicado: (2017)

Pathology of rectal adenocarcinoma following preoperative adjuvant radiotherapy and chemotherapy.
por: Allen, D. C., et al.
Publicado: (1999)

Impact of Time to Surgery on Outcome in Wilms Tumor Treated with Preoperative Chemotherapy
por: Meier, Clemens-Magnus, et al.
Publicado: (2023)

Efficacy of the Preoperative Albumin–Bilirubin Grade for Predicting Survival and Outcomes of Postoperative Chemotherapy for Advanced Gastric Cancer
por: Zhu, Ce, et al.
Publicado: (2020)

Comment on ‘Anthropometric measurements and survival after prostate cancer diagnosis’
por: Dal Maso, Luigino, et al.
Publicado: (2018)

Adjuvant chemotherapy for oesophagogastric cancer with epirubicin, cisplatin and infusional 5-fluorouracil (ECF): a Royal Marsden pilot study.
por: Bamias, A., et al.
Publicado: (1995)

Comment on: Reasons for staying in hospital after video-assisted thoracoscopic surgery lobectomy
por: Shen, Cheng, et al.
Publicado: (2022)

Comment on: “The impact of psychiatric utilisation prior to cancer diagnosis on survival of solid organ malignancies”
por: Braillon, Alain
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_dkt2fepcbt4io466bq0ikm301p